Management of arrhythmias in heart failure. What a practicing physician should know in the current times

Rajesh Ramineni, Mani Kumar Bheemarasetti, Adrian Baranchuk, Tapasya Mandalapu, Venkat K. Mukku, Ken Fujise, Alejandro Barbagelata

Research output: Contribution to journalReview article

Abstract

Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.

Original languageEnglish (US)
Pages (from-to)567-577
Number of pages11
JournalCardiology Journal
Volume19
Issue number6
DOIs
StatePublished - Dec 1 2012

    Fingerprint

Keywords

  • Arrhythmias
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ramineni, R., Bheemarasetti, M. K., Baranchuk, A., Mandalapu, T., Mukku, V. K., Fujise, K., & Barbagelata, A. (2012). Management of arrhythmias in heart failure. What a practicing physician should know in the current times. Cardiology Journal, 19(6), 567-577. https://doi.org/10.5603/CJ.2012.0107